Sanofi SA (SNY) posted weaker-than-expected third quarter revenue as its diabetes treatments continued their long decline while sales of a key multiple sclerosis treatment grew strongly but missed expectations.
Credit Suisse Group (CS) posted a smaller-than-expected third quarter profit Thursday and said it was prepared to meet with activist investors RBR Capital amid speculation it could split into three groups focused on private wealth management, asset management and investment banking.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.
Email
Email sent
Thank you, your email to has been sent successfully.
